My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Neumora Therapeutics, Inc. - Common Stock (NQ:NMRA)

2.240 -0.050 (-2.18%)

Official Closing Price Updated: 1:15 PM EST, Nov 28, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Neumora Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Neumora Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update

November 06, 2025

From Neumora Therapeutics, Inc.

Via GlobeNewswire

Neumora Therapeutics to Participate in Upcoming Conferences in November

November 03, 2025

From Neumora Therapeutics, Inc.

Via GlobeNewswire

Unusual volume stocks in Thursday's session ↗

October 30, 2025

Discover the stocks with unexpected trading volume in today's session on the US markets.

Via Chartmill

Unusual volume stocks in Wednesday's session ↗

October 29, 2025

In today's session, these stocks are experiencing unusual volume.

Via Chartmill

Earnings Scheduled For August 6, 2025 ↗

August 06, 2025

Via Benzinga

Earnings Scheduled For May 12, 2025 ↗

May 12, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

October 27, 2025

Via Benzinga

Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric Modulator NMRA-898

October 27, 2025

From Neumora Therapeutics, Inc.

Via GlobeNewswire

Neumora Therapeutics’ Experimental Drug Demonstrates Weight Loss in Preclinical Studies ↗

October 27, 2025

Neumora said that NMRA-215 demonstrated weight loss of up to 19% as a monotherapy and 26% in combination with Semaglutide.

Via Stocktwits

Neumora Therapeutics Announces Class-Leading Weight Loss Demonstrated with NMRA-215 in Preclinical Diet-Induced Obesity Model

October 27, 2025

From Neumora Therapeutics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 23, 2025

Via Benzinga

Neumora Therapeutics to Host Virtual R&D Day on October 27

October 01, 2025

From Neumora Therapeutics, Inc.

Via GlobeNewswire

This Warner Bros. Discovery Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday ↗

September 16, 2025

Via Benzinga

Neumora Therapeutics to Participate in Upcoming Conferences in September

September 02, 2025

From Neumora Therapeutics, Inc.

Via GlobeNewswire

Neumora (NMRA) Q2 Loss Improves 10% ↗

August 06, 2025

Via The Motley Fool

Topics Artificial Intelligence Intellectual Property

Neumora Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

August 06, 2025

From Neumora Therapeutics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

July 28, 2025

Via Benzinga

Boston Beer Posts Better-Than-Expected Earnings, Joins Scholastic, Deckers Outdoor, Saia And Other Big Stocks Moving Higher On Friday ↗

July 25, 2025

Via Benzinga

Neumora Therapeutics to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025

July 23, 2025

From Neumora Therapeutics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's Intraday Session ↗

July 18, 2025

Via Benzinga

These stocks are moving in today's session ↗

July 09, 2025

Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.

Via Chartmill

Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric Modulator NMRA-861

July 09, 2025

From Neumora Therapeutics, Inc.

Via GlobeNewswire

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

June 09, 2025

The market is filled with gapping stocks in Monday's session. Let's discover which stocks are showing gap-ups and gap-downs.

Via Chartmill

12 Health Care Stocks Moving In Monday's After-Market Session ↗

May 19, 2025

Via Benzinga

Neumora Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

May 12, 2025

From Neumora Therapeutics, Inc.

Via GlobeNewswire

Neumora Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025

April 28, 2025

From Neumora Therapeutics, Inc.

Via GlobeNewswire

NMRA Investors Have Opportunity to Lead Neumora Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

April 07, 2025

From The Schall Law Firm

Via Business Wire

Final NMRA Deadline Reminder: April 7, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP

April 07, 2025

RADNOR, PA - April 7, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Neumora...

Via TheNewswire.com

Topics Lawsuit

Final NMRA Deadline Reminder: April 7, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP

April 07, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Faruqi & Faruqi Reminds Neumora Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 7, 2025 - NMRA

April 06, 2025

From Faruqi & Faruqi LLP

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.